Zhangfa Song

2.3k citations
65 papers · 1.3k indexed · 1 hit paper · h-index 21
Topics
Telomeres, Telomerase, and Senescence (13 papers)Colorectal Cancer Surgical Treatments (9 papers)Colorectal and Anal Carcinomas (8 papers)

In The Last Decade

Zhangfa Song

56 papers receiving 1.3k citations

Hit Papers

The gut microbiota reprograms intestinal lipid metabolism...20232026202420252023255075100

Peers

Zhangfa Song
Comparison fields: 5 of 110
  • Molecular Biology 702
  • Physiology 396
  • Cancer Research 296
  • Oncology 147
  • Immunology 142
Replace Barbara Ascione with:
Barbara Ascione Italy
Hongjun Liu China
Jing Jiang China
Lulu Han China
Catherine Demazy Belgium
Monique N. O’Leary United States
Daisuke Oikawa Japan
Aurélie Bedel France
Valentina Izzo France
Huabing Zhang China
Zhangfa Song relative to Barbara Ascione Italy Barbara Ascione's profile →
Citations per field
00.5×
Barbara Ascione · 1×
Citations per year

Countries citing papers authored by Zhangfa Song

Since Specialization
Citations

This map shows the geographic impact of Zhangfa Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhangfa Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhangfa Song more than expected).

Fields of papers citing papers by Zhangfa Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhangfa Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhangfa Song. The network helps show where Zhangfa Song may publish in the future.

Co-authorship network of co-authors of Zhangfa Song

This figure shows the co-authorship network connecting the top 25 collaborators of Zhangfa Song. A scholar is included among the top collaborators of Zhangfa Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhangfa Song. Zhangfa Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 0
4 1
5 15
6 0
7 17
8 9
9 0
10 2
11 33
12 6
13 38
14 1
15 15
16 32
17 0
18 18
19 5
20 32

About Zhangfa Song

Zhangfa Song is a scholar working on Aging, Oncology and Cancer Research, having authored 65 papers that have together received 1.3k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (13 papers), Colorectal Cancer Surgical Treatments (9 papers) and Colorectal and Anal Carcinomas (8 papers). The work is most often cited by research in Aging (89 citations), Cancer Research (296 citations) and Physiology (396 citations). Zhangfa Song has collaborated with scholars based in China, Germany and United Kingdom. Frequent co-authors include Zhenyu Ju, K. Lenhard Rudolph, Jiaxin Chen, Guido von Figura, Jianbin Xu, Wei Zhou, Qing Meng, Hans A. Kestler, Guolin Zhang and Engeng Chen. Their work appears in journals such as Science, Nucleic Acids Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026